Log in to save to my catalogue

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6338478

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

About this item

Full title

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

Publisher

Washington, DC: Endocrine Society

Journal title

Endocrine reviews, 2019-02, Vol.40 (1), p.236-267

Language

English

Formats

Publication information

Publisher

Washington, DC: Endocrine Society

More information

Scope and Contents

Contents

Abstract
Thyroid-associated ophthalmopathy (TAO) is a complex disease process presumed to emerge from autoimmunity occurring in the thyroid gland, most frequently in Graves disease (GD). It is disfiguring and potentially blinding, culminating in orbital tissue remodeling and disruption of function of structures adjacent to the eye. There are cur...

Alternative Titles

Full title

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6338478

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6338478

Other Identifiers

ISSN

0163-769X

E-ISSN

1945-7189

DOI

10.1210/er.2018-00066

How to access this item